Brief: Enanta Pharmaceuticals Appoints Harry R. Trout As Interim Principal Financial Officer
27/08/2025 21:43
Aug 27 (Reuters) - Enanta Pharmaceuticals Inc ENTA.O: ENANTA PHARMACEUTICALS - APPOINTS HARRY R. TROUT AS INTERIM PRINCIPAL FINANCIAL OFFICER - SEC FILING Further company coverage: ENTA.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enanta Pharmaceuticals
See all newsEnanta Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Enanta Pharmaceuticals Q3 revenue misses estimates, hurt by lower royalties
Enanta Pharmaceuticals Inc expected to post a loss of 51 cents a share - Earnings Preview
Enanta Pharma Q2 loss narrows on higher AbbVie royalties, lower costs
Enanta Pharmaceuticals Q1 revenue beats estimates